Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A PHASE III STUDY IN CHILDREN WITH UNTREATED ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00002798
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:23.603965+00:00
Published At
2013-01-16T00:00:00+00:00
Record Updated At
2013-01-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Childhood Acute Erythroleukemia (M6)", "Childhood Acute Megakaryocytic Leukemia (M7)", "Childhood Acute Monoblastic Leukemia (M5a)", "Childhood Acute Monocytic Leukemia (M5b)", "Childhood Acute Myeloblastic Leukemia With Maturation (M2)", "Childhood Acute Myeloblastic Leukemia Without Maturation (M1)", "Childhood Acute Myelomonocytic Leukemia (M4)", "Childhood Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia", "de Novo Myelodysplastic Syndromes", "Refractory Anemia", "Refractory Anemia With Excess Blasts", "Refractory Anemia With Excess Blasts in Transformation", "Refractory Anemia With Ringed Sideroblasts", "Secondary Myelodysplastic Syndromes", "Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-01-16"
protocolSection.identificationModule.nctId
"NCT00002798"
protocolSection.identificationModule.officialTitle
"A PHASE III STUDY IN CHILDREN WITH UNTREATED ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Childhood Acute Erythroleukemia (M6) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Megakaryocytic Leukemia (M7) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monoblastic Leukemia (M5a) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monocytic Leukemia (M5b) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloblastic Leukemia Without Maturation (M1) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myelomonocytic Leukemia (M4) (protocolSection.conditionsModule.conditions)
  • Childhood Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • de Novo Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Refractory Anemia (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts in Transformation (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Ringed Sideroblasts (protocolSection.conditionsModule.conditions)
  • Secondary Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.